Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.: Long-term follow-up confirms
Healthcare system stakeholders should strive to mitigate treatment delay in patients with locally advanced non-small lung cancer to reduce the risk of intracranial progression. Further research is needed to better understand factors associated with survival, treatment delay, and the development of ...
Five-year survival of stage IIIA-IIIB ( non-N3 ) non-small cell lung cancer patients after platinum/ gemeitabine induction chemotherapy and surgery [ J ]. J Chemother, 2010,22 ( 3 ) : 191-196.Imperatori A, La Salvia D, Rotolo N, et al. Five-year survival of stage IIIA- IIIB ...
In spite of the developments in chemo- and radiotherapy, surgery remains the mainstay of curative treatment of early stage non-small cell lung cancer (NSCLC). In stage Ia/Ib (T1, T2, N0), NSCLC lobectomy offers the best chance for cure, yielding survival rates of between 58 and 76%. ...
Role of immunotherapy in stage III nonsmall cell lung cancer. Despite aggressive treatment based on definitive chemoradiotherapy, 5-year overall survival in unresectable stage III nonsmall cell lung cancer remains poo... Anna,Wrona - 《Current Opinion in Oncology》 被引量: 0发表: 2019年 Phase I...
Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis. J Thorac Oncol. 2014;9(6):834–42. Article PubMed PubMed Central CAS ...
深入研究「Multidisciplinary team discussion results in survival benefit for patients with stage III non-small-cell lung cancer」主題。共同形成了獨特的指紋。 引用此 APA Standard Harvard Vancouver Author BIBTEX RIS Hung, H. Y., Tseng, Y. H., Chao, H. S., Chiu, C. H., Hsu, W....
a分析Ⅲ、Ⅳ期肺癌患者生存的影响因素,为临床评估及预测晚期肺癌患者的预后提供一定的科学依据。 AnalysisⅢ,ⅣThe time lung cancer patient survives the influence factor, provides certain scientific basis for the clinical appraisal and the forecast later period lung cancer patient's prognosis.[translate]...
Among the NSCLC patients with stage III or stage IV disease, the addition of PDT to radiation therapy offers survival benefit over radiation therapy alone. 展开 关键词: non-small cell lung cancer (NSCLC) photodynamic therapy (PDT) National Cancer Database (NCDB) radiation therapy chemotherapy ...
- 1991 - 111 - www.sciencedirect.comdoi:10.1016/0169-5002(91)91761-YLung Cancer